of our platform is the Brainify Datahub, the world’s largest EEG-linked multimodal brain dataset, integrating 2.7M patients, 430K EEGs (including repeat visits), and 90M clinical note Foundational Brain Model (first-of-its-kind)—pretrained on large, heterogeneous cohorts and then fine-tuned on partner data to generate trial-ready treatment-response scores, stability metrics, and SAP-ready biomarker packages. This enables sponsors to design smaller, more powered CNS studies, reduce placebo and heterogeneity noise, and “rescue” at-risk or previously failed assets through biomarker-guided enrichment.

To capture data at scale and standardize measurement, we developed BREEG™, a portable medical-grade EEG system with guided workflows and instant AI-generated reports, suitable for clinic, home, and ICU use. Every test feeds back into our Datahub, strengthening the model and creating a self-reinforcing data network effect. Commercially, Brainify.AI operates three integrated product lines—EEG tests (BREEG + AI reports), Datahub access for pharma, and software applications for cohort building and evidence generation—and is already post-revenue with paying customers, LOIs, and pilots across pharma and provider systems, backed by strategic investors and a growing IP portfolio.